The effect of centrifugation on circulating mRNA quantitation opens up a new scenario in expression profiling from patients with metastatic colorectal cancer

Clinical Biochemistry

Volumn 40, Issue 16-17, 2007, Pages 1277-1284

  Wong, S C Cesar ^a   Ma, Brigette B Y ^a   Lai, Paul B S ^a   Ng, Simon S M ^a   Lee, Janet F Y ^a   Hui, Edwin P ^a   Lam, Money Y Y ^a   Chan, Charles M L ^a   Chan, Anthony T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Centrifugation; Expression profiling; Metastatic colorectal cancer; mRNA; Plasma; Red cells

Indexed keywords

BETA CATENIN; CYTOKERATIN 20; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PADGEM PROTEIN;

ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CENTRIFUGATION; CIRCULATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ERYTHROCYTE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; METASTASIS; MONONUCLEAR CELL; PRESSURE MEASUREMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

BETA CATENIN; CENTRIFUGATION; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; KERATIN-20; NEOPLASM METASTASIS; P-SELECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 35348891041     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.08.006     Document Type: Article

References (36)

1. Fiegl H., Millinger S., Mueller-Holzner E., et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res. 65 (2005) 1141-1145
2. Smirnov D.A., Zweitzig D.R., Foulk B.W., et al. Global gene expression profiling of circulating tumor cells. Cancer Res. 65 (2005) 4993-4997
3. El-Hefnawy T., Raja S., Kelly L., et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem. 50 (2004) 564-573
4. Schuster R., Max N., Mann B., et al. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int. J. Cancer 108 (2004) 219-227
5. Thorn I., Olsson-Stromberg U., Ohlsen C., et al. The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia. Haematologica 90 (2005) 1471-1476
6. Chai V., Vassilakos A., Lee Y., Wright J.A., and Young A.H. Optimization of the PAXgene blood RNA extraction system for gene expression analysis of clinical samples. J. Clin. Lab. Anal. 19 (2005) 182-188
7. Wong S.C., Lo E.S., and Cheung M.T. An optimised protocol for the extraction of non-viral mRNA from human plasma frozen for three years. J. Clin. Pathol. 57 (2004) 766-788
8. Guller U., Zajac P., Schnider A., et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann. Surg. 236 (2002) 768-776
9. Kanellos I., Zacharakis E., Kanellos D., et al. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer. J. Surg. Oncol. 94 (2006) 3-8
10. Silva J.M., Rodriguez R., Garcia J.M., et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 50 (2002) 530-534
11. Silva J.M., Dominguez G., Silva J., et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin. Cancer Res. 7 (2001) 2821-2825
12. Kopreski M.S., Benko F.A., Kwak L.W., and Gocke C.D. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5 (1999) 1961-1965
13. Wong S.C., Lo S.F., Cheung M.T., et al. Quantification of plasma β-catenin mRNA in colorectal cancer and adenoma patients. Clin. Cancer Res. 10 (2004) 1613-1717
14. Ferroni P., Roselli M., Martini F., et al. Prognostic value of soluble P-selectin levels in colorectal cancer. Int. J. Cancer 111 (2004) 404-408
15. Dandachi N., Balic M., Stanzer S., et al. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients. J. Mol. Diagn. 7 (2005) 631-637
16. Ng E.K., Tsui N.B., Lam M.Y., et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48 (2002) 1212-1217
17. Ding C., and Lo Y.M. MALDI-TOF mass spectrometry for quantitative, specific, and sensitive analysis of DNA and RNA. Ann. N. Y. Acad. Sci. 1075 (2006) 282-287
18. Laktionov P.P., Tamkovich S.N., Rykova E.Y., et al. Cell-surface-bound nucleic acids: free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients. Ann. N. Y. Acad. Sci. 1022 (2004) 221-227
19. Bange J., Prechti D., Cheburkin Y., et al. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res. 62 (2002) 840-847
20. Miki C., Inoue Y., Hiro J.I., et al. Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with Dukes A and B colorectal cancer: results of a five-year study. Dis. Colon Rectum 49 (2006) 1710-1718
21. Doviner V., Maly B., and Kaplan V. Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence. Mod. Pathol. 19 (2006) 878-888
22. Nobuhisa T., Naomoto Y., Ohkawa T., et al. Heparanase expression correlates with malignant potential in human colon cancer. J. Cancer Res. Clin. Oncol. 131 (2005) 229-237
23. Sato T., Konishi K., Kimura H., et al. Vascular integrin beta 3 and its relation to pulmonary metastasis of colorectal carcinoma. Anticancer Res. 21 (2001) 643-647
24. Watson-Hurst K., and Becker D. The role of N-Cadherin, MCAM and beta(3) integrin in melanoma progression, proliferation, migration and invasion. Cancer Biol. Ther. 5 (2006) 1375-1382
25. Berney C.R., Fisher R.J., Yang J., Russell P.J., and Crowe P.J. Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int. J. Cancer 89 (2000) 1-7
26. Aldovini D., Demichelis F., Doglioni C., et al. M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int. J. Cancer 119 (2006) 1920-1926
27. Xie S., Luca M., Huang S., et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 57 (1997) 2295-2303
28. Wu G.J., Wu M.W., Wang S.W., et al. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. Gene 279 (2001) 17-31
29. Kristiansen G., Yu Y., Schluns K., Sers C., Dietel M., and Petersen I. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Anal. Cell. Pathol. 25 (2003) 77-81
30. Scearce L.M., Laz T.M., Hazel T.G., Lau L.F., and Taub R. RNR-1, a nuclear receptor in the NGFI-B/Nur77 family that is rapidly induced in regenerating liver. J. Biol. Chem. 268 (1993) 8855-8861
31. Cheng L.E., Chan F.K., Cado D., and Winoto A. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 16 (1997) 1865-1875
32. Martinez-Gonzalez J., Rius J., Castello A., Cases-Langhoff C., and Badimon L. Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ. Res. 92 (2003) 96-103
33. Taniwaki M., Daigo Y., Ishikawa N., et al. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int. J. Oncol. 29 (2006) 567-575
34. Bacac M., Migliavacca E., Stehle J.C., et al. A gene expression signature that distinguishes desmoid tumours from nodular fasciitis. J. Pathol. 208 (2006) 543-553
35. Barzon L., Boscaro M., Pacenti M., Taccaliti A., and Palu G. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. Int. J. Cancer 110 (2004) 914-920
36. Onda M., Nakamura I., Suzuki S., et al. Microsatellite instability in thyroid cancer: hot spots, clinicopathological implications, and prognostic significance. Clin. Cancer Res. 7 (2001) 3444-3449